June Mini Series 2009

Diabetic Neuropathies
1.0 Contact Hours (0.1 CEUs)
UPN 060-000-09-021-L01-P

Cystic Fibrosis and Current Drug Therapy Issues
1.0 Contact Hours (0.1 CEUs)
UPN 060-000-09-022-L01-P

Managing the Geriatric Patient
UPN 060-000-09-023-L01-P
3.0 Contact Hours (0.3 CEUs)

Pharmacy Law Update 2009
UPN 060-000-09-026-L03-P
2.0 Contact Hours (0.2 CEUs – Pharmacy Law)

Program Starts
 

Cystic Fibrosis and Current Drug Therapy Issues
Kelly L. Matson, Pharm.D., Clinical Associate Professor - Pediatrics,
The University of Rhode Island, College of Pharmacy

Learning Objectives:
Upon completion of this knowledge-based program participants will be:

1. Describe cystic fibrosis and its cumulative therapies for lung disease
2. List known cystic fibrosis pathogens and current antimicrobials guidelines
3. Determine activity and effectiveness of novel treatment regimens, including NSAIDs, leukotriene antagonists, and macrolides
4. Summarize literature regarding efficacy and cost analysis of hypertonic saline and rhDNase treatments
    

Diabetic Neuropathies
Lisa Cohen, Pharm.D., CDE, CDOE, Assistant Professor of Pharmacy
The University of Rhode Island, College of Pharmacy

Learning Objectives:
Upon completion of this knowledge-based program participants will be:

1. Describe the pathophysiology of diabetic neuropathies
2. Explain the causes of diabetic neuropathy
3. Discuss pharmacotherapy of treating patients with diabetic neuropathies
4. Apply knowledge of diabetic neuropathy to patient cases

Program Starts
 

General Concepts in Geriatric Pharmacy
Erica Tavares, PharmD, Providence VA Medical Center Pharmacy Resident

Learning Objectives:
Upon completion of this knowledge-based program, participants will be able to:

1. Define the demographic characteristics of elderly patients today
2. Describe the pharmacokinetic and pharmacodynamic changes that are associated with the geriatric population
3. Identify predictors of adverse drug reactions in geriatric patients
4. Identify and recognize potential communication barriers to the geriatric patient and caregiver

The Beers Criteria: Clinical Applications and Considerations for the Geriatric Patient
Michael Barros, PharmD, Providence VA Medical Center Pharmacy Resident

Learning Objectives:
Upon completion of this knowledge-based program, the participant will be able to:

1. Recommend appropriate alternatives for medications on the Beers List
2. Identify medications that are associated with an increase in confusion, dizziness, and falls in the geriatric patient
3. Identify pertinent monitoring parameters for patients taking medications on the Beers List
4. Formulate an appropriate treatment plan to minimize drug adverse drug reactions in the geriatric patient

Issues Facing the Geriatric Patient: Role of the Community Pharmacist
Corinne L. Ewing, PharmD, CVS Caremark Community Practice Resident

Learning Objectives:    Upon completion of this knowledge-based program, the participant will be able to:

1. Define common medication-related problems for community-dwelling geriatric patients;
2. Describe common reasons for medication non-adherence by geriatric patients;
3. Analyze the risk of drug-drug interactions between prescription and over-the-counter medications in this patient population; and
4. Formulate a plan to improve medication safety and adherence for community-dwelling geriatric patients

Current Pharmacotherapeutic Management of Alzheimer's Disease
Fifi Ngin, PharmD, Providence VA Medical Center Pharmacy Resident

Learning Objectives:
Upon completion of this knowledge-based program, participants will be able to:

1. Recognize how current changes in the distribution of Plan B affect pharmacist liability.
2. Prepare to implement new requirements for the labeling of selected OTC pain medications.
3. Discuss recent pharmacy/pharmacist litigation.
4. Explain practice issues driving lawsuits against pharmacists.

Program Starts
 

Pharmacy Law Update 2009

Learning Objectives:
Upon completion of this knowledge-based program participants will be:

1. Able to recognize how current changes in the distribution of Plan B affect pharmacist liability.
2. Prepared to implement new requirements for the labeling of selected OTC pain medications.
3. Familiar with recent pharmacy/pharmacist litigation.
4. Aware of practice issues driving lawsuits against pharmacists.